Midven News

Crescendo Biologics Limited (Crescendo) today announces the appointment of Mike Romanos as Chief Executive Officer. Dr Romanos has been Chief Scientific Officer of the company since May 2009 and has led the formation of the company and the development of its proprietary antibody fragment technologies. During this time, the company has made significant progress in […]

read more

A West Midlands company that has the ultimate goal of increasing pregnancy rates in infertile couples by up to 50%, has received £775,000 in financial backing from a consortium of investors including The Exceed Midlands Advantage Fund. Fertility Focus Limited, which is establishing offices in the Warwick Technology Park, has been backed to the tune […]

read more

Record funding for high growth companies A record £12m of venture capital was invested during the month of December to fund the growth of companies within Midven’s portfolio of investments – the Birmingham-based venture capital company has announced. The investment – into three of the firm’s portfolio companies – reinforces Midven’s approach of investing in […]

read more

1 43 44 45